<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3188">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04327479</url>
  </required_header>
  <id_info>
    <org_study_id>20-9213-BO</org_study_id>
    <nct_id>NCT04327479</nct_id>
  </id_info>
  <brief_title>Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection</brief_title>
  <official_title>Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Essen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Essen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infects host-cells via
      ACE2-receptors, which leads to pneumonia (COVID-19) but also can lead to myocarditis (acute
      myocardial injury) and chronic damage to the cardiovascular system. Therefore, cardiovascular
      protection may be necessary when treating patients with COVID-19 infection. This may
      especially be necessary in patients with cardiovascular diseases, risk factors, and
      co-medication.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 26, 2020</start_date>
  <completion_date type="Anticipated">March 25, 2026</completion_date>
  <primary_completion_date type="Anticipated">March 25, 2026</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>During 1 year follow-up</time_frame>
    <description>mortality of any cause</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>30-day mortality</measure>
    <time_frame>Within 30 days after inclusion</time_frame>
    <description>mortality of any cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiovascular events</measure>
    <time_frame>During 1 year follow-up</time_frame>
    <description>Myocardial infarction, stroke, or CV death</description>
  </secondary_outcome>
  <enrollment type="Anticipated">728</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <condition>Cardiovascular Risk Factor</condition>
  <condition>SARS</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Assessment of cardiovascular diseases and cardiovascular risk factors</intervention_name>
    <description>At inclusion, patients will be screened for pre-existing cardiovascular diseases and cardiovascular risk factors, as well as medication.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The registry will include consecutive patients, tested for suspected SARS-CoV2/Covid-19
        infection at the University Hospital Essen
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with suspected SARS-CoV2/Covid-19 infection

        Exclusion Criteria:

          -  Unwillingness to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tienush Rassaf, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Essen, Deparment of Cardiology and Vascular Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matthias Totzeck, MD</last_name>
    <phone>+49201723</phone>
    <phone_ext>84805</phone_ext>
    <email>matthias.totzeck@uk-essen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amir A Mahabadi, MD</last_name>
    <phone>+49201723</phone>
    <phone_ext>84822</phone_ext>
    <email>amir-abbas.mahabadi@uk-essen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Essen</name>
      <address>
        <city>Essen</city>
        <state>NRW</state>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amir A Mahabadi, MD</last_name>
      <phone>+49201723</phone>
      <phone_ext>84822</phone_ext>
      <email>amir-abbas.mahabadi@uk-essen.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 26, 2020</study_first_submitted>
  <study_first_submitted_qc>March 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 31, 2020</study_first_posted>
  <last_update_submitted>April 24, 2020</last_update_submitted>
  <last_update_submitted_qc>April 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Will be made available upon request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

